Lehigh Valley biopharmaceutical company announces $15M expansion
US Specialty Formulations Announces $15 Million Expansion to Modernize Biopharma Operations
Fact sheet
The independent biotech facility is on a mission to bring a mucosal COVID vaccine to market and mitigate the spread of the virus worldwide
In a race to develop an oral covid-19 vaccine, this small, black-owned bio-tech company has a solution
US specialty formulations wins ben franklin technology partners of northeastern pennsylvania's R. CHADWICK PAUL, JR. INCUBATOR Graduate award
A kinder vaccine coming for cold & flu season
Investors discover a kinder vaccine at J.P. Morgan biotech forum
Research demonstrates benefits of oral covid-19 vaccine
Discover a kinder oral vaccine at the world vaccine congress
USSF to Manufacture Oral Covid-19 Vaccine for 2021 Distribution
Joint Development of Novel Delivery COVID-19 Vaccines Yields Positive Pre-Clinical Results for 2021 Release
US Specialty Formulations Awarded Investment from Ben Franklin Technology Partners